Oral cyanocobalamin is effective in the treatment of vitamin B12 deficiency in crohn’s disease
Resumen: Cobalamin deficiency is common in patients with Crohn’s disease (CD). Intramuscular cobalamin continues to be the standard therapy for the deficiency and maintenance treatment in these patients, although oral route has been demonstrated to be effective in other pathologies with impaired absorption. Our aims were to evaluate the efficacy of oral therapy in the treatment of cobalamin deficiency and in long-term maintenance in patients with Crohn’s disease. We performed a multicenter retrospective cohort study that included 94 patients with Crohn’s disease and cobalamin deficiency. Seventy-six patients had B12 deficiency and 94.7% of them normalized their cobalamin levels with oral treatment. The most used dose was 1 mg/day, but there were no significant differences in treatment effectiveness depending on the dose used (=1 mg/24 h vs. <1 mg/24 h). Eighty-two patients had previous documented B12 deficiency and were treated with oral B12 to maintain their correct cobalamin levels. After a mean follow-up of 3 years, the oral route was effective as maintenance treatment in 81.7% of patients. A lack of treatment adherence was admitted by 46.6% of patients in who the oral route failed. In conclusion, our study shows that oral cyanocobalamin provides effective acute and maintenance treatment for vitamin B12 deficiency caused by CD with or without ileum resection.
Idioma: Inglés
DOI: 10.3390/nu9030308
Año: 2017
Publicado en: Nutrients 9, 3 (2017), 308 [11 pp.]
ISSN: 2072-6643

Factor impacto JCR: 4.196 (2017)
Categ. JCR: NUTRITION & DIETETICS rank: 18 / 81 = 0.222 (2017) - Q1 - T1
Factor impacto SCIMAGO: 1.557 - Nutrition and Dietetics (Q1) - Food Science (Q1)

Tipo y forma: Article (Published version)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.


Exportado de SIDERAL (2021-02-22-07:51:26)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Articles



 Record created 2017-05-02, last modified 2021-02-22


Versión publicada:
 PDF
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)